Zurich Cantonal Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $144M | Buy |
+660,576
| New | +$147M | 0.31% | 52 |
|
|
2025
Q4 | – | Sell |
-928,888
| Closed | -$212M | – | 2541 |
|
|
2025
Q3 | $215M | Sell |
928,888
-26,271
| -3% | -$5.35M | 0.49% | 24 |
|
|
2025
Q2 | $177M | Buy |
955,159
+340,697
| +55% | +$63.3M | 0.43% | 33 |
|
|
2025
Q1 | $129M | Buy |
614,462
+45,964
| +8% | +$8.94M | 0.37% | 44 |
|
|
2024
Q4 | $101M | Sell |
568,498
-29,242
| -5% | -$5.38M | 0.29% | 57 |
|
|
2024
Q3 | $118M | Buy |
597,740
+5,996
| +1% | +$1.12M | 0.35% | 46 |
|
|
2024
Q2 | $101M | Buy |
591,744
+90,378
| +18% | +$15M | 0.33% | 49 |
|
|
2024
Q1 | $91.3M | Buy |
501,366
+94,435
| +23% | +$16.3M | 0.32% | 54 |
|
|
2023
Q4 | $63.1M | Sell |
406,931
-263,502
| -39% | -$38.4M | 0.24% | 77 |
|
|
2023
Q3 | $99.9M | Sell |
670,433
-75,343
| -10% | -$11.1M | 0.44% | 38 |
|
|
2023
Q2 | $100M | Sell |
745,776
-494,172
| -40% | -$72.5M | 0.44% | 40 |
|
|
2023
Q1 | $198M | Buy |
1,239,948
+17,165
| +1% | +$2.62M | 0.96% | 12 |
|
|
2022
Q4 | $198M | Buy |
1,222,783
+13,845
| +1% | +$2.12M | 1.06% | 9 |
|
|
2022
Q3 | $162M | Buy |
1,208,938
+33,777
| +3% | +$4.85M | 0.96% | 11 |
|
|
2022
Q2 | $180M | Buy |
1,175,161
+73,390
| +7% | +$11.2M | 1.05% | 12 |
|
|
2022
Q1 | $179M | Buy |
1,101,771
+151,879
| +16% | +$22.1M | 0.88% | 15 |
|
|
2021
Q4 | $129M | Buy |
949,892
+84
| +0% | +$9.92K | 0.62% | 20 |
|
|
2021
Q3 | $102M | Buy |
949,808
+41,072
| +5% | +$4.69M | 0.55% | 26 |
|
|
2021
Q2 | $102M | Buy |
908,736
+16,616
| +2% | +$1.87M | 0.57% | 27 |
|
|
2021
Q1 | $96.5M | Buy |
892,120
+325,734
| +58% | +$34.8M | 0.57% | 27 |
|
|
2020
Q4 | $60.7M | Sell |
566,386
-44,667
| -7% | -$4.29M | 0.37% | 52 |
|
|
2020
Q3 | $53.5M | Buy |
611,053
+49,701
| +9% | +$4.68M | 0.38% | 54 |
|
|
2020
Q2 | $55.1M | Sell |
561,352
-39,320
| -7% | -$3.46M | 0.48% | 35 |
|
|
2020
Q1 | $45.8M | Sell |
600,672
-12,074
| -2% | -$1.03M | 0.43% | 42 |
|
|
2019
Q4 | $54.3M | Buy |
612,746
+181,771
| +42% | +$15.1M | 0.42% | 41 |
|
|
2019
Q3 | $32.6M | Buy |
430,975
+22,874
| +6% | +$1.57M | 0.27% | 69 |
|
|
2019
Q2 | $29.7M | Sell |
408,101
-6,020
| -1% | -$473K | 0.25% | 78 |
|
|
2019
Q1 | $33.4M | Buy |
414,121
+51,835
| +14% | +$4.24M | 0.3% | 68 |
|
|
2018
Q4 | $33.4M | Sell |
362,286
-58,882
| -14% | -$5.18M | 0.34% | 56 |
|
|
2018
Q3 | $39.8M | Sell |
421,168
-64,322
| -13% | -$6.1M | 0.34% | 53 |
|
|
2018
Q2 | $45M | Sell |
485,490
-58,333
| -11% | -$5.7M | 0.4% | 42 |
|
|
2018
Q1 | $51.5M | Sell |
543,823
-44,310
| -8% | -$4.87M | 0.47% | 33 |
|
|
2017
Q4 | $56.9M | Buy |
588,133
+48,334
| +9% | +$4.56M | 0.51% | 31 |
|
|
2017
Q3 | $48M | Buy |
539,799
+49,118
| +10% | +$3.74M | 0.45% | 43 |
|
|
2017
Q2 | $35.6M | Buy |
490,681
+48,711
| +11% | +$3.27M | 0.35% | 58 |
|
|
2017
Q1 | $28.8M | Buy |
441,970
+10,396
| +2% | +$654K | 0.28% | 80 |
|
|
2016
Q4 | $27M | Buy |
431,574
+13,244
| +3% | +$808K | 0.28% | 78 |
|
|
2016
Q3 | $26.4M | Buy |
418,330
+114,628
| +38% | +$7.42M | 0.27% | 77 |
|
|
2016
Q2 | $18.8M | Sell |
303,702
-78,387
| -21% | -$4.78M | 0.24% | 92 |
|
|
2016
Q1 | $21.8M | Buy |
382,089
+24,904
| +7% | +$1.39M | 0.28% | 82 |
|
|
2015
Q4 | $21.2M | Buy |
357,185
+46,540
| +15% | +$2.68M | 0.27% | 78 |
|
|
2015
Q3 | $16.9M | Buy |
310,645
+16,989
| +6% | +$1.11M | 0.24% | 99 |
|
|
2015
Q2 | $19.7M | Buy |
293,656
+45,943
| +19% | +$3M | 0.27% | 87 |
|
|
2015
Q1 | $14.5M | Buy |
247,713
+91,111
| +58% | +$5.5M | 0.2% | 120 |
|
|
2014
Q4 | $10.2M | Buy |
156,602
+38,187
| +32% | +$2.41M | 0.31% | 63 |
|
|
2014
Q3 | $6.84M | Buy |
118,415
+5,062
| +4% | +$281K | 0.22% | 97 |
|
|
2014
Q2 | $6.4M | Buy |
113,353
+13,968
| +14% | +$733K | 0.19% | 124 |
|
|
2014
Q1 | $5.11M | Sell |
99,385
-1,683
| -2% | -$85.1K | 0.16% | 140 |
|
|
2013
Q4 | $5.34M | Sell |
101,068
-83,063
| -45% | -$4.08M | 0.17% | 126 |
|
|
2013
Q3 | $8.24M | Buy |
184,131
+6,273
| +4% | +$278K | 0.28% | 79 |
|
|
2013
Q2 | $7.35M | Buy |
+177,858
| New | +$7.78M | 0.26% | 96 |
|
Other funds holding ABBV
VCM
VPM
Zurich Cantonal Bank's ABBV Position: Q1 2026 in Review
Zurich Cantonal Bank opened a new position in AbbVie (ABBV) in Q1 2026: 660,576 shares worth $144M. The stake represents 0.31% of the portfolio and ranks #52 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in ABBV as recently as Q3 2025.
Zurich Cantonal Bank first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $215M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Zurich Cantonal Bank held 660,576 shares of AbbVie worth $144M as of Q1 2026.
- AbbVie was a new Zurich Cantonal Bank position in Q1 2026.
- AbbVie made up 0.31% of Zurich Cantonal Bank's portfolio in Q1 2026, its #52 holding.
- Zurich Cantonal Bank first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Zurich Cantonal Bank's AbbVie position peaked at $215M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.